Table 2.
Medication Types among Study Participants
| Control | SPD | SZ | Relatives | |
|---|---|---|---|---|
| No medications | 54 | 24 | 7 | 29 |
| Atypical antipsychotic | 0 | 1 | 28 | 3 |
| Conventional antipsychotic | 0 | 0 | 8 | 1 |
| Antidepressant | 0 | 2 | 15 | 1 |
| Anticonvulsant | 0 | 1 | 5 | 1 |
| Anticholinergic | 0 | 0 | 5 | 0 |
| Benzodiazepine | 0 | 0 | 9 | 1 |
| Sedative | 2 | 0 | 4 | 2 |
Note. Patients taking psychotropic medications typically used multiple medications. One schizophrenia patient was taking lithium. One participant with schizotypal personality disorder was taking a stimulant (ephedrine). The medication status of two SZ patients is unknown due to participation in double-blind drug trials at time of testing.